Australia markets open in 5 hours 35 minutes

Diaceutics PLC (DXRX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
120.50+0.50 (+0.42%)
At close: 04:29PM BST

Diaceutics PLC

Building Two
First Floor Dataworks at Kings Hall Health and Wellbeing Park
Belfast BT9 6GW
United Kingdom

https://www.diaceutics.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees184

Key executives

NameTitlePayExercisedYear born
Mr. Ryan KeelingCEO & Director282.49kN/A1982
Mr. Peter KeelingFounder & Executive Director310.99kN/A1960
Mr. Nicholas Stewart RobertsCFO & Director193.05kN/A1982
Ms. Julie BrowneInterim Chief Operating OfficerN/AN/AN/A
Ken RuppelVice President of Scientific & Medical ServicesN/AN/AN/A
Ms. Gillian ShawGeneral CounselN/AN/AN/A
Amie McNieceVice President of MarketingN/AN/AN/A
Mr. Jordan ClarkChief Data Officer?N/AN/AN/A
Ms. Susanne MunkstedChief Precision Medicine OfficerN/AN/AN/A
Ms. Jillian BeggsChief Commercial OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Corporate governance

Diaceutics PLC’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.